NOVEL MASS-SPECTRAL FRAGMENTATION OF HEPTAFLUOROBUTYRYL DERIVATIVES OF ACYL ANALOGS OF PLATELET-ACTIVATING-FACTOR

被引:6
|
作者
WEINTRAUB, ST [1 ]
PINCKARD, RN [1 ]
HEATH, TG [1 ]
GAGE, DA [1 ]
机构
[1] MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824
基金
美国国家卫生研究院;
关键词
D O I
10.1016/1044-0305(91)80034-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Direct derivatization of the acyl analogue of platelet-activating factor (acyl-PAF) with hepatafluorobutyric anhydride results in replacement of the phosphocholine moiety with a heptafluorobutyryl (HFB) group. Electron capture (EC) mass spectrometric analysis of this compound that makes use of negative ion detection along with subsequent accurate mass measurement and tandem mass spectrometry studies revealed that in addition to expected fragmentation due to losses of elements of HF, ketene, and/or acetic acid, there is a rearrangement reaction between the HFB group and the substituent on carbon-2 of the glycerol backbone. For 2-acetyl isomers, this fragmentation yields a characteristic ion at m/z 237; for 1-acetyl isomers, the analogous ion is observed at [M-135]-, along with a corresponding carboxylate anion. The use of the HFB derivative is invaluable for analysis of PAF homologues and analogues because it provides detailed structural information in combination with the high sensitivity of a gas chromatography combined with EC-mass spectrometry assay.
引用
收藏
页码:476 / 482
页数:7
相关论文
共 50 条
  • [21] NOVEL STRUCTURAL SPECIFICITIES FOR SELECTIVE MONOCYTE ACTIVATION BY PLATELET-ACTIVATING-FACTOR (PAF) ANALOGS AND ANTAGONISTS
    VALONE, FH
    RUIS, NM
    BARTHELSON, RA
    CLINICAL RESEARCH, 1991, 39 (02): : A272 - A272
  • [22] DEVELOPMENT OF A NOVEL SERIES OF TRIALKOXYARYL DERIVATIVES AS SPECIFIC AND COMPETITIVE ANTAGONISTS OF PLATELET-ACTIVATING-FACTOR
    SAWYER, DA
    BEAMS, RM
    BLACKWELL, GJ
    BROCKWELL, MA
    CHEESMAN, NJ
    DEMAINE, DA
    GARLAND, LG
    HODSON, HF
    HYDE, RM
    ISLIP, PJ
    JACKSON, WP
    PARKE, AJ
    ROSE, VS
    SMITH, S
    TILLING, L
    WATES, PJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (12) : 2130 - 2137
  • [23] CHEMOENZYMATIC APPROACH TO CARBOHYDRATE-DERIVED ANALOGS OF PLATELET-ACTIVATING-FACTOR
    NICOTRA, F
    PANZA, L
    RUSSO, G
    ZUCCHELLI, L
    JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (07): : 2154 - 2158
  • [24] DIKETOPIPERAZINE DERIVATIVES, A NEW SERIES OF PLATELET-ACTIVATING-FACTOR INHIBITORS
    SHIMAZAKI, N
    SHIMA, I
    HEMMI, K
    TSURUMI, Y
    HASHIMOTO, M
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1987, 35 (08) : 3527 - 3530
  • [25] STIMULATION OF TUMOR-NECROSIS-FACTOR RELEASE BY CYTOTOXIC ANALOGS OF PLATELET-ACTIVATING-FACTOR
    VALONE, FH
    RUIS, NM
    IMMUNOLOGY, 1992, 76 (01) : 24 - 29
  • [26] MASS-SPECTRAL FRAGMENTATION PATHWAYS OF 2,4-SULTAM DERIVATIVES
    DOSS, SH
    HANNA, AG
    REVUE ROUMAINE DE CHIMIE, 1993, 38 (01) : 27 - 34
  • [27] ANALOGS OF PLATELET-ACTIVATING-FACTOR .4. SOME MODIFICATIONS OF THE PHOSPHOCHOLINE MOIETY
    WISSNER, A
    SCHAUB, RE
    SUM, PE
    KOHLER, CA
    GOLDSTEIN, BM
    JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (03) : 328 - 333
  • [28] SYNTHESIS OF AZATHIA-ANALOGS OF PLATELET-ACTIVATING-FACTOR CONTAINING A METHIONINOL BACKBONE
    ZEIDLER, JM
    ZIMMERMANN, W
    ROTH, HJ
    CHEMISTRY AND PHYSICS OF LIPIDS, 1990, 56 (2-3) : 175 - 183
  • [29] CHEMICAL SYNTHESIS AND PHYSIOLOGICAL-ACTIVITY OF SULFONIUM ANALOGS OF PLATELET-ACTIVATING-FACTOR
    KATES, M
    ADAMS, GA
    BLANK, ML
    SNYDER, F
    LIPIDS, 1991, 26 (12) : 1095 - 1101
  • [30] CONFORMATION AND ACTIVITY OF TETRAHYDROFURAN LIGNANS AND ANALOGS AS SPECIFIC PLATELET-ACTIVATING-FACTOR ANTAGONISTS
    BIFTU, T
    GAMBLE, NF
    DOEBBER, T
    HWANG, SB
    SHEN, TY
    SNYDER, J
    SPRINGER, JP
    STEVENSON, R
    JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (10) : 1917 - 1921